Hormone Receptor-Positive Metastatic Breast Cancer — An Interview with Dr Adam M Brufsky on the Impact of Biomarkers and Existing Comorbidities on the Selection of First-Line Therapy

From Oncology Today with Dr Neil Love Dr. Neil Love

Dr Adam M Brufsky from the University of Pittsburgh discusses first-line treatment selection for patients with HR-positive metastatic breast cancer and preexisting medical conditions.

CME information and select publications here.

Community discussion

Join the conversation

Hormone Receptor-Positive Metastatic Breast Cancer — An Interview with Dr Adam M Brufsky on the Impact of Biomarkers and Existing Comorbidities on the Selection of First-Line Therapy

You May Also Like

Cryptids Of The Corn

Arroe Collins Forest Stories

Real Ghost Stories Online

Tommy Cullum's Let's Get Freaky

Dumma Människor

Vedanta Cast

Mundo Insólito Radio

This Week in Microbiology

The Grave Talks | Haunted, Paranormal & Supernatural

Head Shepherd